Exicure, Inc. (XCUR)
NASDAQ: XCUR · Real-Time Price · USD
2.610
-0.080 (-2.97%)
Jun 25, 2026, 9:41 AM EDT - Market open
Exicure Market Cap
Exicure has a market cap or net worth of $16.64 million as of June 25, 2026. Its market cap has decreased by -72.64% in one year.
Market Cap
16.64M
Enterprise Value
14.56M
1-Year Change
-72.64%
Ranking
Category
Stock Price
$2.61
Market Cap Chart
Since May 22, 2018, Exicure's market cap has decreased from $122.30M to $16.64M, a decrease of -86.40%. That is a compound annual growth rate of -21.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 16.64M | -51.78% |
| Dec 31, 2025 | 34.50M | 16.16% |
| Dec 31, 2024 | 29.70M | 494.00% |
| Dec 29, 2023 | 5.00M | -12.28% |
| Dec 30, 2022 | 5.70M | -67.98% |
| Dec 31, 2021 | 17.80M | -88.47% |
| Dec 31, 2020 | 154.40M | -28.95% |
| Dec 31, 2019 | 217.30M | 42.03% |
| Dec 31, 2018 | 153.00M | 25.10% |
| May 22, 2018 | 122.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NewcelX | 18.79M |
| Tempest Therapeutics | 18.51M |
| Passage Bio | 18.35M |
| Pasithea Therapeutics | 18.01M |
| Werewolf Therapeutics | 17.99M |
| GT Biopharma | 17.69M |
| CEL-SCI | 17.65M |
| AEON Biopharma | 17.34M |